M.D.C. Shares Climb on Sale Agreement With Japan's Sekisui House
By Sabela Ojea
Shares of M.D.C. Holdings on Thursday climbed after the company said it is selling itself to Japan's Sekisui House at a premium price.
At 9:47 a.m. ET, shares were up 18% at $62.72. The stock has surged 67% in the past three months.
The Denver-based construction company said Sekisui House is acquiring the group in an all-cash $4.9 billion deal that would make Sekisui the fifth largest housebuilder in the U.S.
Each M.D.C. shareholder would receive $63 per share in cash, representing an about 19% premium to its closing stock price of $53.09 Wednesday.
The acquisition would also help Sekisui House achieve its target of supplying 10,000 homes outside of Japan by fiscal 2025, ahead of initial expectations, Sekisui House's Chief Executive Yoshihiro Nakai said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
January 18, 2024 10:22 ET (15:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?